We are live on ! Find out more
LP

Longview Partners Portfolio holdings

AUM $7.06B
1-Year Est. Return 3.43%
This Fund
S&P 500
This Quarter Est. Return
+8.05%
1 Year Est. Return
-3.43%
3 Year Est. Return
+28.48%
5 Year Est. Return
+46.59%
10 Year Est. Return
+218.87%
AUM
$15.4B
AUM Growth
+$242M
Cap. Flow
-$914M
Cap. Flow %
-5.94%
Top 10 Hldgs %
48.51%
Holding
28
New
1
Increased
1
Reduced
25
Closed
1

Top Buys

Rank Stock Value
1
STT icon
State Street
STT
+$339M
2
MD icon
Pediatrix Medical
MD
+$68.1M

Top Sells

Rank Stock Value
1
TEL icon
TE Connectivity
TEL
+$395M
2
DG icon
Dollar General
DG
+$94.9M
3
PH icon
Parker-Hannifin
PH
+$78.8M
4
PGR icon
Progressive
PGR
+$61.8M
5
AON icon
Aon
AON
+$55.7M

Sector Composition

Rank Sector Weight
1 Healthcare 28.88%
2 Financials 26.01%
3 Technology 21.72%
4 Industrials 16.31%
5 Consumer Discretionary 4.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AON icon
1
Aon
AON
$80.4B
$782M 5.08%
6,585,387
-482,600
-7% -$55.7M
HCA icon
2
HCA Healthcare
HCA
$91.8B
$771M 5.02%
8,666,856
-510,193
-6% -$42.5M
PH icon
3
Parker-Hannifin
PH
$119B
$765M 4.98%
4,772,882
-519,290
-10% -$78.8M
APTV icon
4
Aptiv
APTV
$12.3B
$762M 4.96%
9,472,595
-525,323
-5% -$39.4M
ZBH icon
5
Zimmer Biomet
ZBH
$18.7B
$746M 4.85%
6,291,783
-344,634
-5% -$39.1M
BNY
6
Bank of New York Mellon
BNY
$104B
$746M 4.85%
15,792,286
-931,000
-6% -$43.5M
PGR icon
7
Progressive
PGR
$129B
$725M 4.72%
18,511,772
-1,618,994
-8% -$61.8M
EMR icon
8
Emerson Electric
EMR
$81.7B
$724M 4.71%
12,097,338
-681,960
-5% -$40.7M
FIS icon
9
Fidelity National Information Services
FIS
$23.9B
$723M 4.7%
9,076,014
-492,450
-5% -$39.6M
UNH icon
10
UnitedHealth
UNH
$386B
$715M 4.65%
4,359,337
-252,716
-5% -$41.4M
ORCL icon
11
Oracle
ORCL
$339B
$693M 4.51%
15,530,569
-786,900
-5% -$32.8M
WTW icon
12
Willis Towers Watson
WTW
$30.1B
$663M 4.31%
5,066,287
-241,509
-5% -$30.7M
WFC icon
13
Wells Fargo
WFC
$258B
$663M 4.31%
11,907,673
-612,600
-5% -$34.8M
IQV icon
14
IQVIA
IQV
$40.4B
$661M 4.3%
8,205,921
-266,845
-3% -$20.8M
GWW icon
15
W.W. Grainger
GWW
$64.5B
$659M 4.29%
2,831,758
-157,426
-5% -$38.8M
TMO icon
16
Thermo Fisher Scientific
TMO
$213B
$640M 4.16%
4,166,951
-200,575
-5% -$30.7M
ACN icon
17
Accenture
ACN
$106B
$634M 4.12%
5,289,311
-266,870
-5% -$31.9M
PFE icon
18
Pfizer
PFE
$144B
$591M 3.84%
18,212,607
-771,001
-4% -$24.3M
FISV
19
Fiserv Inc
FISV
$29.7B
$573M 3.72%
9,931,276
-834,724
-8% -$46.9M
TEL icon
20
TE Connectivity
TEL
$60.1B
$360M 2.34%
4,823,419
-5,365,510
-53% -$395M
TMX
21
DELISTED
Terminix Global Holdings, Inc.
TMX
$359M 2.34%
12,852,146
-666,102
-5% -$17.3M
STT icon
22
State Street
STT
$48.9B
$341M 2.22%
+4,279,400
New +$339M
OMC icon
23
Omnicom Group
OMC
$23.7B
$327M 2.12%
3,787,409
-195,392
-5% -$16.7M
MD icon
24
Pediatrix Medical
MD
$2.17B
$316M 2.06%
4,555,631
+980,081
+27% +$68.1M
ARW icon
25
Arrow Electronics
ARW
$10.4B
$196M 1.28%
2,676,226
-159,649
-6% -$11.7M

Similar funds

Longview Partners's Q1 2017 Portfolio in Review

As of Q1 2017, Longview Partners held 28 positions worth $15.4B, up 1.6% from $15.1B the previous quarter. Its ten largest holdings account for 49% of the portfolio.

Longview Partners withdrew a net $914M in Q1 2017, closing 1 position and reducing 25 holdings. Its most notable exit was Dollar General, an estimated $94.9M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 29% of assets, up from 28% a quarter earlier, followed by Financials and Technology.

Against the trend, Longview Partners opened a new position in State Street worth $341M.

  • Longview Partners's largest Q1 2017 buy was State Street: 4,279,400 shares worth $341M.
  • Longview Partners added most to Pediatrix Medical in Q1 2017, an estimated $68.1M increase.
  • Longview Partners's biggest Q1 2017 reduction was TE Connectivity, cutting an estimated $395M.
  • Longview Partners fully exited Dollar General in Q1 2017, selling an estimated $94.9M.
  • Longview Partners's ten largest holdings make up 49% of its $15.4B portfolio in Q1 2017.
  • Longview Partners opened 1 new position and closed 1 in Q1 2017.
  • Longview Partners's portfolio value rose 1.6% quarter-over-quarter to $15.4B.

Based on Longview Partners's 13F filing for Q1 2017, filed 8 May 2017.